Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Medical Genetics

Recognizing Red Flags and Handling Emergencies

At a Glance

For people with methylmalonic acidemia with homocystinuria, repeated vomiting, inability to drink, extreme sleepiness, confusion, dark or reduced urine, swelling, seizures, or breathing trouble can signal a metabolic emergency. Follow the written emergency plan and seek urgent care.

Managing Methylmalonic Acidemia with Homocystinuria (MMA-HCU) means becoming deeply familiar with your own body—or your child’s. Most days will likely be defined by routine management, but because this condition affects how every cell in the body produces energy and clears waste, certain “triggers” can cause a rapid buildup of toxins. This is known as metabolic decompensation [1].

Understanding the difference between a routine illness and a medical emergency is the most powerful tool you have for staying safe. You must have a written 24/7 sick-day algorithm from your treating team. General guidelines cannot replace the specific instructions your metabolic geneticist provides.

When to Call the Metabolic Clinic

Not every sniffle requires an ER visit, but early communication is critical. You should contact your metabolic team according to your individualized sick-day plan if you notice:

  • Any fever, stomach bug, or common cold. (Note: The specific temperature threshold depends on the patient’s age and clinical status).
  • A decrease in appetite or inability to maintain prescribed carbohydrate and fluid intake [2].
  • Mild fatigue where the person is still alert and acting like themselves.

Urgent “Red Flags”: When to Go to the ER

The following symptoms indicate that the body’s metabolic balance is failing or that a serious complication is occurring. Do not wait—follow your emergency letter and go to the nearest Emergency Room immediately if you see any of these:

1. Signs of Metabolic Crisis

  • Severe Vomiting or Lethargy: If a person cannot keep fluids down, has repeated diarrhea, or is “floppy,” extremely sleepy, or difficult to wake up [3].
  • Neurological Changes: Sudden trouble walking (ataxia), new tremors, seizures, or a dramatic change in mental state (confusion, aggression, or hallucinations) [4][1].

2. Renal/Blood Emergencies (TMA and HUS)

MMA-HCU can cause Thrombotic Microangiopathy (TMA) or Hemolytic Uremic Syndrome (HUS), where small blood clots damage organs and red blood cells break apart [5].

  • Dark or Reduced Urine: Urine that looks like tea or cola, or a significant drop in how much someone is peeing [6].
  • Bruising and Pallor: Unusual bruising, tiny red spots on the skin (petechiae), or looking very pale/yellow (jaundice) [7].
  • Swelling: New swelling (edema) in the legs, face, or abdomen [8].

When to Call Emergency Services (911)

Call emergency services immediately for life-threatening events, such as:

  • Active seizures.
  • Unresponsiveness or inability to wake the person.
  • Severe Breathing Difficulty: Rapid breathing, extreme shortness of breath, or turning blue around the lips (cyanosis)—which can be signs of Pulmonary Hypertension (PH) [9][10].

Common Triggers

Metabolic decompensation doesn’t usually happen for no reason. It is often “triggered” by stress on the body. Common triggers include:

  • Infections: Flu, stomach bugs (gastroenteritis), or even common viruses [11][12].
  • Fasting and Dehydration: Going too long without eating or being unable to keep food down [13].
  • Catabolic Stress: Major life events like surgery, pregnancy, or the period immediately after giving birth (postpartum) [14].
    (Note: Physical activity is generally encouraged as tolerated, provided you maintain proper hydration and nutrition. Intense physical exertion is primarily a risk if it leads to dehydration, fasting, or catabolic stress [1].)

Age Matters: How Symptoms Differ

  • In Infants (Early-Onset): Watch for “failure to thrive” (not gaining weight), poor feeding, and low muscle tone (hypotonia). Babies may also have seizures or a smaller-than-average head size [3][12].
  • In Adults/Teens (Late-Onset): Symptoms are often psychiatric or neurological. You might see a sudden decline in school or work performance, mood swings, “brain fog,” or weakness and numbness in the legs [4][15].

The Emergency Letter: Your Most Important Document

Because MMA-HCU is extremely rare, most ER doctors will not know how to treat it. They may mistakenly try to treat a metabolic crisis like a “normal” stomach bug.

You must have a current, clinician-signed, weight-based Emergency Protocol or Emergency Letter from your metabolic geneticist [7]. This letter should clearly state:

  1. The diagnosis (cblC defect / MMA-HCU).
  2. The need for specific IV fluids (including dextrose concentrations) to stop the body from breaking down its own tissue.
  3. The exact dose and route of hydroxocobalamin (B12) to be given immediately [16].
  4. Contact information for your metabolic specialist, who should be involved in care right away.

Keep a copy in your car, your bag, and on your phone at all times. In an emergency, your job is to hand this letter to the triage nurse and ask the ER to contact the metabolic specialist immediately. You should never attempt to self-adjust emergency doses.

Common questions in this guide

What are the emergency warning signs of MMA-HCU?
Warning signs include repeated vomiting or diarrhea with inability to keep fluids down, extreme sleepiness or difficulty waking, seizures, confusion, sudden trouble walking, or major behavior changes. Dark or reduced urine, unusual bruising, tiny red spots, pallor or jaundice, and new swelling can signal kidney or blood complications. Severe breathing difficulty, blue lips, unresponsiveness, or active seizures require immediate emergency services.
When should someone with MMA-HCU go to the emergency room?
Go to the emergency room immediately when a person with MMA-HCU cannot keep fluids down, becomes very sleepy or difficult to wake, develops neurological changes, has dark or reduced urine, or shows unusual bruising, swelling, or jaundice. Use the written emergency letter and ask the emergency team to contact the metabolic specialist. For milder illness, such as a fever or reduced appetite while the person remains alert, follow the individualized sick-day plan and contact the metabolic clinic promptly.
When should I call 911 for MMA-HCU?
Call 911 for active seizures, unresponsiveness or inability to wake the person, severe breathing difficulty, very rapid breathing, or blue lips. These signs can indicate a life-threatening emergency and should not be managed at home.
What should an MMA-HCU emergency letter include?
The emergency letter should identify the diagnosis, including cblC defect or MMA-HCU, and provide a current weight-based treatment protocol. It should state the needed intravenous fluid and dextrose concentrations, the exact hydroxocobalamin dose and route, and direct contact information for the metabolic specialist. Keep copies accessible and do not change emergency doses yourself.
What can trigger a metabolic crisis in MMA-HCU?
Infections, fasting, dehydration, vomiting, surgery, pregnancy, and the period after giving birth can place enough stress on the body to trigger metabolic decompensation. Physical activity is generally encouraged as tolerated, but it becomes a concern if it causes dehydration, inadequate nutrition, or prolonged fasting. Follow the sick-day and hydration plan from the metabolic team during illness or other stress.
How can MMA-HCU symptoms differ in infants and older children or adults?
Infants may have poor feeding, failure to gain weight, low muscle tone, seizures, or a smaller-than-average head size. Older children, teens, and adults may develop a sudden decline in school or work performance, mood changes, brain fog, weakness, or numbness in the legs. Any sudden or severe change should be discussed promptly with the metabolic team and evaluated urgently when red flags are present.

Get notified when new evidence is published on Methylmalonic acidemia with homocystinuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Late-onset cblC deficiency around puberty: a retrospective study of the clinical characteristics, diagnosis, and treatment.

    Chen Z, Dong H, Liu Y, et al.

    Orphanet journal of rare diseases 2022; (17(1)):330 doi:10.1186/s13023-022-02471-x.

    PMID: 36056359
  2. 2

    Do not Miss Rare and Treatable Cause of Early-Onset Hemolytic Uremic Syndrome: Cobalamin C Deficiency.

    Topaloglu R, İnözü M, Gülhan B, et al.

    Nephron 2019; (142(3)):258-263 doi:10.1159/000497822.

    PMID: 31137025
  3. 3

    [Kidney disease in cobalamin C deficiency].

    Lemoine M, Grangé S, Guerrot D

    Nephrologie & therapeutique 2019; (15(4)):201-214 doi:10.1016/j.nephro.2019.03.011.

    PMID: 31130431
  4. 4

    Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic review.

    Arhip L, Brox-Torrecilla N, Romero I, et al.

    Orphanet journal of rare diseases 2024; (19(1)):20 doi:10.1186/s13023-024-03021-3.

    PMID: 38245797
  5. 5

    Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.

    Beck BB, van Spronsen F, Diepstra A, et al.

    Pediatric nephrology (Berlin, Germany) 2017; (32(5)):733-741 doi:10.1007/s00467-016-3399-0.

    PMID: 27289364
  6. 6

    Cobalamin c deficiency associated with antifactor h antibody-associated hemolytic uremic syndrome in a young adult.

    Philipponnet C, Desenclos J, Brailova M, et al.

    BMC nephrology 2020; (21(1)):96 doi:10.1186/s12882-020-01748-2.

    PMID: 32164588
  7. 7

    Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children.

    Li QL, Song WQ, Peng XX, et al.

    World journal of pediatrics : WJP 2015; (11(3)):276-80 doi:10.1007/s12519-015-0032-4.

    PMID: 26253414
  8. 8

    Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.

    Barlas UK, Kıhtır HS, Goknar N, et al.

    Pediatric nephrology (Berlin, Germany) 2018; (33(6)):1093-1096 doi:10.1007/s00467-018-3941-3.

    PMID: 29558000
  9. 9

    [Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].

    Liu XQ, Yan H, Qiu JX, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; (49(5)):768-777.

    PMID: 29045954
  10. 10

    Pulmonary hypertension in late-onset Methylmalonic Aciduria and Homocystinemia: a case report.

    Wen LY, Guo YK, Shi XQ

    BMC pediatrics 2020; (20(1)):243 doi:10.1186/s12887-020-02130-9.

    PMID: 32443968
  11. 11

    Newborn Screening for Methylmalonic Acidemia in a Chinese Population: Molecular Genetic Confirmation and Genotype Phenotype Correlations.

    Zhou W, Li H, Wang C, et al.

    Frontiers in genetics 2018; (9()):726 doi:10.3389/fgene.2018.00726.

    PMID: 30728829
  12. 12

    The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening.

    Ling S, Wu S, Shuai R, et al.

    Frontiers in genetics 2022; (13()):805599 doi:10.3389/fgene.2022.805599.

    PMID: 35242167
  13. 13

    Case Report: A Case of Late-Onset Combined Methylmalonic Acidemia and Hyperhomocysteinemia Induced by a Vegetarian Diet.

    Xu B, Zhang L, Chen Q, et al.

    Frontiers in pediatrics 2022; (10()):896177 doi:10.3389/fped.2022.896177.

    PMID: 35903162
  14. 14

    Encephalitis-like presentation of methylmalonic acidemia with homocystinuria in a postpartum woman: a case report.

    Wang Q, Ji Z, Wang Y, Qi Z

    Frontiers in psychiatry 2026; (17()):1734901 doi:10.3389/fpsyt.2026.1734901.

    PMID: 41890422
  15. 15

    Late-onset cblC defect: clinical, biochemical and molecular analysis.

    Ding S, Ling S, Liang L, et al.

    Orphanet journal of rare diseases 2023; (18(1)):306 doi:10.1186/s13023-023-02890-4.

    PMID: 37770946
  16. 16

    First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

    Olivieri G, Bordugo A, Burnyte B, et al.

    Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.

    PMID: 42231716

This page is for informational purposes only and does not constitute medical advice. Follow your individualized sick-day plan and emergency letter, and contact your metabolic team or emergency services for urgent concerns.